RE:MARI - $3 SHORT TERM Price Target - German source DGAP-Media / 12.07.2018 / 08:20 Company: Maricann Group Inc. WKN: A2DQR6 Reason for the report: Update Recommendation: Strong Buy Target price medium term: 3.00 EUR Long-term price target: 5.00 EUR Million cash flow secured by further cannabis supply agreement - share massively undervalued! Our cannabis top pick the Canadian Maricann (WKN A2DQR6) announced another supply agreement. This is already the third delivery agreement within a very short time and a guarantor for fast millions of sales. As Maricann (WKN A2DQR6) reported, a letter of intent was signed with Liquor Distribution Branch ("BCLDB", British Columbia Liquor Store). As a preferred licensed producer, the company will initially deliver approximately 3,621,900 grams (about 3,622kg) of non-medical cannabis to BCLDB for the first 12 months after legalization. The most important points - Maricann was selected to deliver cannabis for consumption to the British Columbia market. - The Company agrees to provide at least 3,621,900 grams per year for BCLDB. - Maricann now has confirmed allocations of cannabis for consumption to Manitoba, Alberta and British Columbia with an annualized volume of 10,923,100 grams (approximately 10,923kg). "Maricann is excited to sign a letter of intent with BCLDB and we are proud to partner with them during this exciting market launch phase," said Geoff Kosar, vice president of sales and marketing, Maricann Group Inc. Existing supply agreements: Most recently, two supply agreements have been concluded to supply the market in Alberta and Manitoba with cannabis products. On June 29, 1818, the company announced that it has signed a supply agreement with Manitoba Liquor & Lotteries Corporation (MLCC), which marks an important milestone for the company. The supply agreement provides for 550,000 grams of various cannabis products within the first 12 months. On July 5, 1818, the company announced that it has entered into a supply agreement with Alberta Gaming, Liquor & Cannabis Commission. The delivery volume is 3,375 kilograms for a period of 6 months! Maricann has now consistently produced THC distillates at its facilities in Langton, Ontario, a building block for future gourmet products and pre-dosed pharmaceutical products. Maricann used thin-film distillation to process the material. "We realize and develop all aspects of the business in accordance with our plan to provide forward momentum to our shareholders, with a focus on maintaining margins through business unit development and additional capabilities as a business for a fraction of the cost in this sector Government regulators continue to support our company by placing their trust in us as one of a handful of medical cannabis and product licensing companies, and we are proud of the progress we have made to date in strategically segmenting our business by geography, strategic investment, Improve quality and science-rich products developed by knowledgeable and qualified professionals over the long term, "said Ben Ward, CEO ...
Comprehensive corporate update: The company is in discussion with several other provinces for 2018 and 2019 and will announce, when permissible, when these agreements will be closed. While there are no guarantees that additional supply agreements will be signed, ongoing discussions with certain provinces have confirmed a high regard for the company's capabilities and competitiveness in line with much larger companies in the industry. Extension of the plant in Langton Construction on the expansion of the Company's facility at 138 8th Concession Road, Langton, Ontario (the "Langton facility") is making further progress. By mid-November 2018 (subject to the receipt of the relevant licenses from Health Canada), Maricann expects to be able to produce 706kg of dried cannabis per week during Phase 1 of the expansion of its Langton facility. By April 2019, Maricann expects to be able to produce 2,023 kg of dried cannabis per week at a total cost of goods sold of approximately $ 1.30 per gram per week. These figures are based on the assumption that all building permits, items with long delivery times such. B. HVAC devices are delivered in time for Langton plant. Operation Update Germany Maricann completed the conversion of the 4.600m2 (approximately 49,000 square foot) facility for the import of narcotic drugs and distribution in Ebersbach, Germany. The plant was visited by the European Medicines Agency without any significant complaints. The company will issue another update when the final approval of the regulatory authorities has been granted. This certification, if obtained, will allow Maricann to import its own EMA-GMP certified products and certified products of others for distribution in Germany and the rest of Europe, where legal, and maintain a profit margin, in most cases at 50% of Wholesale price is. Malta and VESIsorb (R) Update As expected, Maricann has received confirmation from Malta Enterprise (the country's official business development agency) in the form of a Memorandum of Understanding to proceed with the licensing of finished medicinal cannabis manufacturing facilities. Malta is an integral part of Maricann's long-term development strategy, including manufacturing of finished products using the patented VESISorb (R) delivery technology. The superiority of VESISorb (R) has been demonstrated time and again in well-designed pilot studies and peer-reviewed published pharmacokinetic absorption studies and bioavailability studies.